Compatibility study of topical 0.25% hypericin (HyBryteTM) application in subjects with mycosis fungoides: Results of the HPN‐CTCL‐02 study

• Main Authors: Carolina V. Alexander‐Savino (Author), Adam Rumage (Author), Christopher Pullion (Author), Richard Straube (Author), Christopher J. Schaber (Author), Elaine S. Gilmore (Author), Brian Poligone (Author)
• Formato: Libro
• Publicado: Wiley, 2024-09-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Abstract Background HyBryteTM is a photodynamic therapy of topical hypericin that has recently been shown to be safe and efficacious in early stage cutaneous T‐cell lymphoma (CTCL). However, its efficacy, absorption, and effect on heart function parameters in patients who require greater HyBryteTM e...